Methode Electronics recently concluded fiscal 2026 with strategic divestitures and ongoing portfolio realignment, notably exiting its Medical segment and divesting parts of its Interface business. The company continues to serve diverse end markets including automotive, industrial, and commercial sectors with custom engineered mechatronic solutions. Key operational themes include responding to evolving automotive electrification trends, managing supply chain complexities, and sustaining innovation through targeted R&D. Despite competitive pressures and customer concentration risks, Methode leverages its engineering capabilities, global footprint, and intellectual property to maintain customer relationships. Its financial position shows positive liquidity but net losses were reported in the latest fiscal year, underscoring execution challenges.